CAS No. 114870-03-0
Batch:
Purity:97
Chemical Structure
Check the
Fondaparinux Sodium (Org 31540)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxyoxan-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylate | |
|---|---|---|
| CAS Number | 114870-03-0 | |
| Molecular Formula |
C31H43N3O49S8.10Na |
|
| Molecular Weight (MW) | 1728.08 | |
| SMILES | COC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] | |
| InChIKey | XEKSTYNIJLDDAZ-JASSWCPGSA-D |
Fondaparinux Sodium (Org 31540) is a synthetic glucopyranoside antithrombotic agent that targets antithrombin III and activated factor X (Factor Xa). By selectively binding to antithrombin III, it potentiates the innate neutralization of Factor Xa by antithrombin. This selective inhibition disrupts the blood coagulation cascade, downstream suppressing thrombin generation and fibrin clot formation to exert antithrombotic activity. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| Water | 100 mg/mL |
| DMSO |
Insoluble
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Ethanol | Insoluble |
| Water | 100 mg/mL |
| DMSO |
Insoluble
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Ethanol | Insoluble |
| Water | 100 mg/mL |
| DMSO |
60 mg/mL
(34.72 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | Insoluble |
| Water | 100 mg/mL |
| DMSO |
1 mg/mL
(0.57 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Fondaparinux Sodium (Org 31540) Clinical Trials
- Fondaparinux Sodium (Org 31540) Solubility in DMSO
- Fondaparinux Sodium (Org 31540) Stock Solution
- Fondaparinux Sodium (Org 31540) Storage
- Fondaparinux Sodium (Org 31540) Stability
- Fondaparinux Sodium (Org 31540) Molecular Weight
- Fondaparinux Sodium (Org 31540) SMILES
- Fondaparinux Sodium (Org 31540) Chemical Structure (2D and 3D)
- Fondaparinux Sodium (Org 31540) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.